Delta Describe, the French Collaborative Project: The Profile and Management of Hepatitis Delta Patients in Metropolitan France

. Most patients knew the year of their delta diagnosis, and 69.1% knew their fibrosis stage. Liver-related events occurred in 14.3% (67/468) of patients, mainly comprising portal hypertension (61.6%), liver failure (12.3%), and hepatocellular carcinoma (26%), and 45 patients (45/468) underwent liver transplantation. At the time of the survey, 47.1% of the patients reported undetectable HDV RNA; 40.6% (222/547) had currently or previously undergone BLV treatment. Among patients receiving ongoing treatment for HDV at the time of the survey, 84.8% were receiving nucleos(t)ide analogs (NUCs). In metropolitan France, HDV patients had access to specialized follow-up care and innovative therapies (bulevirtide), were mostly on NUCs, and demonstrated good disease awareness.

Authors

Institutions

Publication Details

Journal
Viruses
Published
2026-03-31
DOI
https://doi.org/10.3390/v18040424
Primary Topic
Hepatitis B Virus Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Delta Describe, the French Collaborative Project: The Profile and Management of Hepatitis Delta Patients in Metropolitan France

Céline Rigaud, Isaac Fassler, Ségolène Brichler, Benoît Visseaux et al.
Viruses
Hepatitis B Virus Studies
article

Delta Describe, the French Collaborative Project: The Profile and Management of Hepatitis Delta Patients in Metropolitan France

Céline Rigaud, Isaac Fassler, Ségolène Brichler, Benoît Visseaux, Pascale Trimoulet, Dominique Roulot, Cécile Brouard, Stéphane Chevaliez, Sonia Burrel, Aurélie Guigon, Anaïs Soares, Vincent Quentin, E Billaud, S. Alain, Veronique Loustaud-Ratti, Marie Bosselut, Karine Saune, Dadi Abel Diédhiou, Gérard Lina, André-Jean Remy, Paul Carrier, Marianne Coste-Burel, Marc Bourlière, Jean-Pierre Bronowicki, Delta Describe Study Group, Hélène Fontaine, Marilyne Debette-Gratien, Anne-Marie Roque-Afonso, Jacques Izopet, Sandrine François, Bernard Castan, Katell Peoc’h, Jérôme Boursier
article en

Abstract

. Most patients knew the year of their delta diagnosis, and 69.1% knew their fibrosis stage. Liver-related events occurred in 14.3% (67/468) of patients, mainly comprising portal hypertension (61.6%), liver failure (12.3%), and hepatocellular carcinoma (26%), and 45 patients (45/468) underwent liver transplantation. At the time of the survey, 47.1% of the patients reported undetectable HDV RNA; 40.6% (222/547) had currently or previously undergone BLV treatment. Among patients receiving ongoing treatment for HDV at the time of the survey, 84.8% were receiving nucleos(t)ide analogs (NUCs). In metropolitan France, HDV patients had access to specialized follow-up care and innovative therapies (bulevirtide), were mostly on NUCs, and demonstrated good disease awareness.

VirusesVol. 18(4)
Université de Bordeaux (FR), Inserm (FR), Université Fédérale de Toulouse Midi-Pyrénées (FR), Université Paris-Est Créteil (FR), Société Nationale des Chemins de Fer Français (France) (FR), Université de Lille (FR), Hôpital Beaujon (FR), Centre Hospitalier Universitaire de Nantes (FR), Société de Réanimation de Langue Française (FR), Lille’s Cardiology Hospital (FR), Université Sorbonne Paris Nord (FR), Santé Publique France (FR), Assistance Publique – Hôpitaux de Paris (FR), Hospices Civils de Lyon (FR), Bordeaux Population Health (FR), Hôpital Saint Joseph (FR), Centre d'Investigation Clinique de Nantes (FR), Hôpital Avicenne (FR), Hôpitaux Universitaires Henri-Mondor (FR), Association of French Motorway Companies (FR), Hôpitaux de Saint Maurice (FR), Ceramic Synthesis and Functionalization Laboratory (FR), Eurofins (France) (FR), Groupe Hospitalier Intercommunal Le Raincy Montfermeil (FR), Hôpital Paul-Brousse (FR), Université de Limoges (FR), HCL Technologies (India) (IN), Nantes Université (FR)
Gilead Sciences
Partnerships for the goals
Openalex Percentile: Top 33%
Hepatitis B Virus Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.